|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From St. Mary Hospital, Hoboken, NJ; and the University of Medicine and Dentistry of New Jersey-Newark Medical School, Newark, NJ.
Correspondence to: Nicholas J. Demos, MS, MD, 142 Palisade Ave, Jersey City, NJ 07306
A case report is presented of spontaneous chylothorax successfully treated by conservative means. The helpful role of the inhibitory peptide, octreotide, is discussed.
Key Words: chylothorax octreotide
This article has been cited by other articles:
![]() |
F. X. McCormack Lymphangioleiomyomatosis: A Clinical Update Chest, February 1, 2008; 133(2): 507 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tibballs, R. Soto, and T. Bharucha Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion Ann. Thorac. Surg., June 1, 2004; 77(6): 2213 - 2215. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Walther, P. Theune, I. Sullivan, and M. R. de Leval Successful medical treatment of persistent pleural drainage after the Fontan operation Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 348 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Dauriat, O. Brugiere, H. Mal, J. Camuset, Y. Castier, G. Leseche, and M. Fournier Refractory chylothorax after lung transplantation for lymphangioleiomyomatosis successfully cured with instillation of povidone J. Thorac. Cardiovasc. Surg., September 1, 2003; 126(3): 875 - 877. [Full Text] [PDF] |
||||
![]() |
D. Mikroulis, V. Didilis, G. Bitzikas, G. Bougioukas, and N. J. Demos Octreotide in the Treatment of Chylothorax Chest, June 1, 2002; 121(6): 2079 - 2081. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |